Table 1.
Character of breast cancer metastases to the endometrium
| Author | Age | Tumor type | TNM stage | Metastases sites | Recurrence interval | Follow up | ER | PR | HER-2 |
|---|---|---|---|---|---|---|---|---|---|
| Fumikata Hara9 | 44 | Lobular | cT3aN1M0 | Endometrium | 2.5 years | Died in 11 months | + | − | − |
| Arslan D10 | 57 | Ductal | T1bN3aM0 | Endometrium myometrium | 2 years | Alive | + | + | − |
| Karvouni E5 | 51 | Ductal | TxN1M0 | Endometrium liver, bone | 3 years | Died in 4 months | + | − | − |
| Erkanli S11 | 63 | Lobular | Unknown | Endometrium | 8 months | Alive | + | + | − |
| Scopa CD12 | 50 | Lobular | T3N3M0 | Endometrium cervix, ovary | 3 years | Died in 18 months | + | + | + |
| Scopa CD12 | 81 | Lobular | T1N3M0 | Endometrium corpus | 2 years | Died in 6 months | + | + | − |
| Sinkre P13 | 58 | Metapl astic | T2N0M0 | Endometrium corpus, ovary | 4 years | Alive 1 year | − | + | − |
| Giordano G14 | 77 | Lobular | T2N1M0 | Endometrium | 20 years | Died in 2 months | No | No | No |
| Giordano G14 | 72 | Lobular | T2N1M0 | Endometrium myometrium ovary, cervix | 6 years | Alive 4 months | + | + | No |
| Kennebeck CH15 | 71 | Ductal | T1N1M0 | Endometrium cervix | 2.5 years | Alive 10 months | − | − | − |
| Al-brahim N16 | 53 | Lobular | T2N1M0 | Endometrium | 4 years | No | + | − | No |
| Ramalingam P17 | 59 | Microp apillary | IIIA | Endometrium bladder | 2 years | Alive 3 months | + | + | No |
| Our case | 66 | Ductal | T2N0M0 | Endometrium | 11 years | Alive | − | − | − |
+: positive
−: negative
no: unclear. ER, estrogen receptor
HER-2, human epidermal growth factor receptor 2
PR, progesterone receptor
TNM, tumor node metastasis.